INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

SPHERA FUNDS MANAGEMENT LTD.'s Holding History (CIK: 0001496201)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 1,191,140 Value ($000) $1,084 Avg Close — Range —
Q4 2024
Shares 1,191,140 Value ($000) $3,299 Avg Close — Range —
Q3 2024
Shares 1,191,140 Value ($000) $6,230 Avg Close — Range —
Q2 2024
Shares 1,462,724 Value ($000) $6,524 Avg Close — Range —
Q1 2024
Shares 1,372,907 Value ($000) $10,516 Avg Close — Range —
Q4 2023
Shares 1,562,907 Value ($000) $6,658 Avg Close — Range —
Q3 2023
Shares 1,234,907 Value ($000) $5,187 Avg Close — Range —
Q2 2023
Shares 1,131,967 Value ($000) $6,305 Avg Close — Range —
Q1 2023
Shares 1,781,858 Value ($000) $10,210 Avg Close — Range —
Q4 2022
Shares 1,625,058 Value ($000) $1,706 Avg Close — Range —
Q3 2022
Shares 1,175,058 Value ($000) $3,149 Avg Close — Range —
Q2 2022
Shares 1,165,600 Value ($000) $5,560 Avg Close — Range —
Q3 2020
Shares 196,411 Value ($000) $5,164 Avg Close — Range —